RT Journal Article
SR Electronic
T1 Machine Learning Analysis of Chest CT Scan Images as a Complementary Digital Test of Coronavirus (COVID-19) Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.13.20063479
DO 10.1101/2020.04.13.20063479
A1 Al-Karawi, Dhurgham
A1 Al-Zaidi, Shakir
A1 Polus, Nisreen
A1 Jassim, Sabah
YR 2020
UL http://medrxiv.org/content/early/2020/04/17/2020.04.13.20063479.abstract
AB This paper reports on the development and performance of machine learning schemes for the analysis of Chest CT Scan images of Coronavirus COVID-19 patients and demonstrates significant success in efficiently and automatically testing for COVID-19 infection. In particular, an innovative frequency domain algorithm, to be called FFT-Gabor scheme, will be shown to predict in almost real-time the state of the patient with an average accuracy of 95.37%, sensitivity 95.99% and specificity 94.76%. The FFT-Gabor scheme is adequately informative in that clinicians can visually examine the FFT-Gabor feature to support their final diagnostic.Key Strengths The proposed FFT-Gabor scheme is an automatic machine learning scheme that works in real time and achieves significantly high accuracy with very low false negative, and can provide supporting evidences of the predicted decision by visually displaying the final features upon which decision is made. This scheme will be most beneficial when used in addition to the RT-PCR swab test of non-symptomatic cases.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialhistorical data sets available on public domainClinical Protocols https://github.com/UCSD-AI4H/COVID-CT Funding StatementNo fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesnon https://github.com/UCSD-AI4H/COVID-CT